Apolipoprotein E and Alzheimer disease: Genotype-specific risks by age and sex

American Journal of Human Genetics

Volumn 60, Issue 2, 1997, Pages 439-446

  Bickeböller, Heike ^a,c   Campion, Dominique ^d,e   Brice, Alexis ^b   Amouyel, Philippe ^f   Hannequin, Didier ^d   Didierjean, Olivier ^b   Penet, Christiane ^b   Martin, Cosette ^d   Pérez Tur, Jordi ^a   Michon, Agnès ^b   Dubois, Bruno ^b   Ledoze, François ^a   Thomas Anterion, Catherine ^h   Pasquier, Florence ^g   Puel, Michèle ^a   Demonet, Jean François ^a   Moreaud, Olivier ⁱ   Babron, Marie Claude ^a   Meulien, Didier ^j   Guez, David ^j   Chartier Harlin, Marie Christine ^a   Frebourg, Thierry ^d   Agid, Yves ^b   Martinez, Maria ^a   Clerget Darpoux, Françoise ^a   more..

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e CHS du Rouvray   (France)

^f INSTITUT PASTEUR DE LILLE   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j IRIS Institut de Recherches Internationales Servier   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; ARTICLE; DISEASE PREDISPOSITION; GENE DOSAGE; GENETIC RISK; GENOTYPE; HUMAN; HUMAN TISSUE; PENETRANCE; PRIORITY JOURNAL; SEX RATIO;

AGE OF ONSET; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SEX CHARACTERISTICS;

EID: 2642711806     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. ACMG/ASHG (American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer Disease) (1995) Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA 274:1627-1629
2. APA (American Psychiatric Association) (1987) Diagnostic and statistical Manual of Mental Disorders, 3d ed, rev. American Psychiatric Association, Washington, DC
3. Amouyel P, Cottel D, Berr C, Vidai O, Brousseau Th (1994) ε4 allele of the apolipoprotein E gene is a potent risk factor for cognitive impairment. Neurobiol Aging 15, Suppl 1:S43
4. Bird TD (1995) Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol 38: 2-3
5. Breslow N (1996) Statistics in epidemiology: the case-control study. J Am Soc Stat 91:14-28
6. Breslow NE, Day NE (eds) (1980) Statistical methods in cancer research. I. The analysis of case-control studies. International Agency for Research on Cancer, Lyon.
7. Breteler MB, Claus JL, Van Duijn CM, Launer LJ, Hofman A (1992) Epidemiology of Alzheimer disease. Epidemiol Rev 14:59-82
8. Chartier-Harlin MC, Parfitt M, Legrain S, Pérez-Tur J, Brousseau Th, Evans A, Berr C, et al (1994) Apolipoprotein E ε4 allele as a major risk factor for sporadic early- and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 3:569-574
9. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA et al (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7:180-184
10. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, et al (1995a) Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 45:1323-1328
11. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Roses AD, Pericak-Vance MA, et al (1995b) The apolipoprotein E ε4 allele and sex-specific risk of Alzheimer's disease. JAMA 273:373-374
12. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923
13. Cumming AM, Robertson FW (1984) Polymorphism at the apolipoprotein-E locus in relation to risk of coronary disease. Clin Genet 25:310-313
14. Dai XY, Nanko S, Hattori M, Fukuda R, Nagata K, Isse K, Ueki A, Kazamatsuri H (1994) Association of apolipoprotein ε4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci Lett 175:74-76
15. Fleiss JL (1981) Statistical methods for rates and proportions. John Wiley & Son, New York
16. Folstein MF, Folstein SE, McHugh PR (1975) "Mini Mental State" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
17. Frisoni GB, Govoni S, Geroldi C, Bianchetti A, Calabresi L, Franceschini G, Trabucchi M (1995) Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 37:596-604
18. Hixson JE, Vernier DT (1990) Restriction isotyping of human apoE by gene amplification and cleavage with HhaI. Lipid Res 31:545-548
19. Jarvik GP, Larson EB, Goddard K, Kukull WA, Schellenberg GD, Wijsman EM (1996) Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet 58:191-200
20. Kuusisto J, Koivisto K, Kervinen K, Mykkänen L, Helkala EL, Vanhanen MM, Hänninen T, et al (1994) Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. Br Med J 309:636-638
21. Kuusisto J, Mykkänen L, Kervinen K, Kesaniemi YA, Laakso M (1995) Apolipoprotein ε4 phenotype is not important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vascul Biol 15:1280-1286
22. Laakso M, Kesaniemi A, Kervinen K, Jauhiainen M, Pyörälä K (1991) Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes. Br Med J 303:1159-1162
23. Lenzen HJ, Assmann G, Buchwalsky R, Schulte H (1986) Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem 32:778-781
24. Lehtovirta M, Helisalmi S, Mannermaa A, Soininen H, Koivisto K, Ryynänen M, Riekkinen P (1995) Apolipoprotein E polymorphism and Alzheimer's disease in eastern Finland. Neurosci Lett 185:13-15
25. Locke PA, Conneally PM, Tanzi RE, Gusella JF, Haines JL (1995) Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early and late-onset cases. Genet Epidemiol 12:83-92
26. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
27. Martinez M, Campion D, Babron MC, Hannequin D, Agid Y, Bellis M, Brice A, et al (1996) Segregation analysis of Alzheimer pedigrees: rare Mendelian dominant mutation(s) explain a minority of early-onset cases. Am J Med Genet 67:9-12
28. Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang MX, Maestre G, Colleen N, et al (1993) The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 34: 752-754
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34:939-944
30. Myers RH, Schaefer EJ, Wilson PWF, d'Agostino R, Ordovas JM, Espino A, Au R, et al (1996) Apolipoprotein E4 association with dementia in a population based study: the Framingham study. Neurology 46:673-677
31. Norrman J, Brookes AJ, Yates C, St Clair D (1995) Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease. Br J Psychiatr 167:533-536
32. Payami H, Montee KR, Kaye JA, Bird TD, Yu CE, Wijsman EM, Schellenberg GD (1994) Alzheimer's disease, apolipoprotein E4, and gender. JAMA 271:1316-1317
33. Payami H, Zareparsi S, Montee KR, Sexton GJ, Kaye JA, Bird TD, Yu C-E, et al (1996) Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 58:803-811
34. Pérez-Tur J, Campion D, Martinez M, Brice A, Tardieu S, Hannequin D, Agid Y, et al (1995) Evidence for ApoE ε4 association in early-onset Alzheimer's disease patients with late onset relatives. Am J Med Genet 60:550-553
35. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699
36. Robins J, Breslow N, Greenland S (1986) Estimates of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models. Biometrics 42:311-323
37. Rocca WA, Hofman A, Brayne C, Breteler MMB, Clarke M, Copeland JRM, Dartigues JF, et al (1991) Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. Ann Neurol 30:381-390
38. Roses AD (1995) Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 38:6-14
39. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, et al (1993) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472
40. Schoenberg B, Kokmen E, Okazaki H (1987) Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 22:724-729.
41. Smith AD, Johnston C, Sim E, Nagy Z, Jobst KA, Hindley N, King E (1994) Protective effect of ApoE ε2 in Alzheimer's disease. Lancet 344:473-474
42. Sorbi S, Nacmias B, Forleo P, Latorraca S, Gobbini I, Bracco L, Piacentini S, Amaducci L (1994) Apo E allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 177:100-102
43. St Clair D, Rennie M, Slorach E, Norrman J, Yates C, Carothers A (1995) Apolipoprotein E ε4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers. J Med Genet 32: 642-644
44. Strittmatter WJ, Roses AD (1995) Apolipoprotein E and Alzheimer's disease. Proc Natl Acad Sci USA 92:4725-4727
45. Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A (1994) Protection against Alzheimer's disease with apoE ε2. Lancet 343:1432-1433
46. Tang M-X, Maestre G, Tsai W-Y, Liu X-H, Feng L, Chung W-Y, Chun M, et al (1996) Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet 58:574-584
47. Thompson WD, Weissman MM (1981) Quantifying lifetime risk of psychiatric disorders. J Psychiatr Res 16:113-126
48. Tsai M-S, Tangalos EG, Petersen RC, Smith GE, Schaid DJ, Kokmen E, Ivnik RJ, et al (1994) Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 54:643-649
49. Tsuda T, Lopez R, Rogaeva EA, Freedman M, Rogaev E, Drachman D, Pollen D, et al (1994) Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium ? Ann Neurol 36:97-100
50. Van Bockxmeer FM, Mamotte CDS (1992) Apolipoprotein ε4 homozygosity in young men with coronary heart disease. Lancet 340:879-880
51. Van-Duijn CM, Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van-Broeckhoven C (1994) Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 7:74-78
52. Van Duijn CM, Knijff P, Wehnert A, Voecht JD, Bronzova JB, Havekes LM, Hofman A (1995) The apolipoprotein E ε2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 37: 605-610
53. Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, Arinami T, Oguni E, Mizusawa H, Shoji S, et al (1994) Dose-dependent association of apolipoprotein E allele ε4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 36: 656-659